ENC1 and colorectal carcinoma: In a study involving 100 paired CRC and adjacent normal tissue samples, circXRN2 was found to promote CRC cell proliferation and metastasis via the miR-149-5p/ENC1/EMT axis, suggesting that circXRN2 may serve as a potential therapeutic target and a novel biomarker for CRC progression (134).